Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 110,868 shares at $60.00 ($6.7M) on 2019-06-19, disclosed to the SEC on 2019-06-21.
Open-market sale of $6.7M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NVCR | SELL | 2020-03-10 | $316K | — | Filing → |
| NVCR | SELL | 2020-03-02 | $386K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |